(Q48952359)

17 February 2018

title

Neonatal iron potentiates adult MPTP-induced neurodegenerative and functional deficits. (English)

1 reference

17 February 2018

1 reference

N Schröder

2

1 reference

ORCID Public Data File 2021

author name string

A Fredriksson

1

1 reference

17 February 2018

P Eriksson

3

1 reference

17 February 2018

I Izquierdo

4

1 reference

17 February 2018

T Archer

5

1 reference

17 February 2018

publication date

1 April 2001

1 reference

17 February 2018

number of pages

9

1 reference

Parkinsonism and Related Disorders

inferred from page(s)

published in

1 reference

17 February 2018

volume

7

1 reference

17 February 2018

issue

2

1 reference

17 February 2018

page(s)

97-105

1 reference

17 February 2018

A histochemical study of iron-positive cells in the developing rat brain

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Iron in brain function and dysfunction with emphasis on Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Infusion of iron into the rat substantia nigra: nigral pathology and dose-dependent loss of striatal dopaminergic markers.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Magnetic resonance imaging in parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Free radicals in brain metabolism and pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Iron-overload disease in infants involving fetal growth retardation, lactic acidosis, liver haemosiderosis, and aminoaciduria

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

The role of transition metals in the pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Hallervorden-Spatz Syndrome and Brain Iron Metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Increased nigral iron content in postmortem parkinsonian brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

The potential role of iron chelators in the treatment of Parkinson's disease and related neurological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Developmental changes in transferrin and iron uptake by the brain in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Transferrin and iron uptake by the brain: effects of altered iron status

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

An autoradiographic study of the uptake and distribution of iron by the brain of the young rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Ontogeny of Adrenergic Arousal and Cholinergic Inhibitory Mechanisms in the Rat

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Exposure to an organophosphate (DFP) during a defined period in neonatal life induces permanent changes in brain muscarinic receptors and behaviour in adult mice

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Exposure to DDT during a defined period in neonatal life induces permanent changes in brain muscarinic receptors and behaviour in adult mice

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

MPTP neurotoxicity: an overview and characterization of phases of toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

MPTP-induced hypoactivity in mice: reversal by L-dopa.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Dissociation between biochemical and behavioral recovery in MPTP-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

MPTP-induced behavioural and biochemical deficits: a parametric analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Synergistic interactions between NMDA-antagonists and L-dopa on activity in MPTP-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Synergistic interactions between COMT-/MAO-inhibitors and L-Dopa in MPTP-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Effect of the competitive NMDA antagonist, CGP 40 116, and a low dose of l-Dopa on the motor activity deficit of MPTP-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Neonatal iron exposure induces neurobehavioural dysfunctions in adult mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Maze learning and motor activity deficits in adult mice induced by iron exposure during a critical postnatal period.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Behavioural pharmacology of glutamate receptors in the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Central noradrenaline depletion antagonizes aspects of d-amphetamine-induced hyperactivity in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Derivatives of cis-2-amino-8-hydroxy-1-methyltetralin: mixed 5-HT1A-receptor agonists and dopamine D2-receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Behavioural effects of prenatal metallic mercury inhalation exposure in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Behavioural effects of neonatal metallic mercury exposure in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Prenatal coexposure to metallic mercury vapour and methylmercury produce interactive behavioural changes in adult rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Cognitive changes in mice following moderate MPTP exposure.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Frontal cognitive impairments and saccadic deficits in low-dose MPTP-treated monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Neurobehavioral dysfunctions associated with dietary iron overload.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Progressive changes in striatal dopaminergic markers, nigral volume, and rotational behavior following iron infusion into the rat substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Increased iron in the substantia nigra compacta of the MPTP-lesioned hemiparkinsonian African green monkey: evidence from proton microprobe elemental microanalysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Excessive iron accumulation in the brain: a possible potential risk of neurodegeneration in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Iron overload and mitochondrial diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Iron-mediated bioactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in glial cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

The Pivotal Role of Iron in NF-kappaB Activation and Nigrostriatal Dopaminergic Neurodegeneration: Prospects for Neuroprotection in Parkinson's Disease with Iron Chelators

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

Autoradiographic localization and density of [125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900028-6

7 January 2021

10.1016/S1353-8020(00)00028-6

Identifiers

DOI

1 reference

17 February 2018

PubMed ID

11248590

1 reference

17 February 2018